High Tower Advisors, LLC Bridge Bio Pharma, Inc. Transaction History
High Tower Advisors, LLC
- $64.2 Billion
- Q2 2024
A detailed history of High Tower Advisors, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 201,254 shares of BBIO stock, worth $4.99 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
201,254
Previous 199,262
1.0%
Holding current value
$4.99 Million
Previous $6.16 Million
17.27%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding BBIO
# of Institutions
292Shares Held
175MCall Options Held
8.66MPut Options Held
2.76M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$770 Million45.4% of portfolio
-
Viking Global Investors LP25.1MShares$623 Million2.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$349 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$309 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$150 Million67.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.68B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...